- » Aim and Scope
- » Section Policies
- » Publication Frequency
- » Open Access Policy
- » Archiving
- » Peer-Review
- » Indexation
- » Publishing Ethics
- » Founder and Publisher
- » Author Fees
- » Disclosure and Conflict of Interest
- » Borrowing and Plagiarism
- » Article Retraction
- » Advertising and Reprints Circulation
Aim and Scope
The aim of the journal is to support continuing medical education of specialists involved in the diagnosis and treatment of oncologic diseases.
Objective of the journal: publication of up-to-date information in the field of surgery and oncology, on modern achievements and results of research in this field.
Target audience: oncologists, surgeons, chemotherapists, radiologists, specialists in radiation diagnostics and therapy, pathomorphologists, anesthesiologists, endoscopists, geneticists.
Content: modern opportunities in diagnostics and treatment of oncologic and benign diseases are covered. Priority in the journal is given to the publication of the results of original research. The editorial board pays attention to the completeness of the presentation of information, which should ensure the reproducibility of the presented results. The results of individual clinical observations devoted to the treatment of rare diseases or the application of unique treatment technologies are published. The journal also presents literature reviews in which a systematic search of the material or meta-analysis of published data was conducted.
Section Policies
Open SubmissionsPublication Frequency
4 issues per year
Open Access Policy
"Pelvic Surgery and Oncology" is an open access journal. All articles are made freely available to readers immediatly upon publication.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition - it means that articles have free availability on the public internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from gaining access to the internet itself.
For more information please read BOAI statement.
Archiving
- Scientific library of National Electronic Information Consortium (NEICON), Russia;
- Russian State Library (Moscow);
Peer-Review
A double-blind peer review method is mandatory for processing of all scientific manuscripts submitted to the editorial stuff of "Pelvic Surgery and Oncology". This implies that neither the reviewer is aware of the authorship of the manuscript, nor the author maintains any contact with the reviewer.
- The publication reviews all materials submitted to the editorial office that correspond to its subject matter in order to assess them. All reviewers are recognized experts on the subject of peer-reviewed materials and have published on the subject of the reviewed article within the last 3 years.
- Members of the editorial board and leading Russian and international experts in corresponding areas of life sciences, invited as independent readers, perform peer reviews. Editor-in-chief, deputy editor-in-chief or science editor choose readers for peer review. We aim to limit the review process to 2-4 weeks, though in some cases the schedule may be adjusted at the reviewer’s request.
- Reviewer has an option to abnegate the assessment should any conflict of interests arise that may affect perception or interpretation of the manuscript. Upon the scrutiny, the reviewer is expected to present the editorial board with one of the following recommendations:
– to accept the paper in its present state;
– to invited the author to revise their manuscript to address specific concerns before final decision is reached;
– that final decision be reached following further reviewing by another specialist;
– to reject the manuscript outright. - If the reviewer has recommended any refinements, the editorial staff would suggest the author either to implement the corrections, or to dispute them reasonably. Authors are kindly required to limit their revision to 2 months and resubmit the adapted manuscript within this period for final evaluation.
- We politely request that the editor be notified verbally or in writing should the author decide to refuse from publishing the manuscript. In case the author fails to do so within 3 months since receiving a copy of the initial review, the editorial board takes the manuscript off the register and notifies the author accordingly.
- If author and reviewers meet insoluble contradictions regarding revision of the manuscript, the editor-in-chief resolves the conflict by his own authority.
- The editorial board reaches final decision to reject a manuscript on the hearing according to reviewers’ recommendations, and duly notifies the authors of their decision via e-mail. The board does not accept previously rejected manuscripts for re-evaluation.
- Upon the decision to accept the manuscript for publishing, the editorial staff notifies the authors of the scheduled date of publication.
- Kindly note that positive review does not guarantee the acceptance, as final decision in all cases lies with the editorial board. By his authority, editor-in-chief rules final solution of every conflict.
- The editorial board of the publication sends copies of licenses or a reasoned refusal to the authors of the submitted materials, and also undertakes to send copies of reviews to the Ministry of Education and Science of the Russian Federation upon receipt of a corresponding request to the editorial office of the publication.
- Original reviews of submitted manuscripts remain deposited for 5 years.
Indexation
Articles in "Pelvic Surgery and Oncology" are indexed by several systems:
- Russian Scientific Citation Index (RSCI) – a database, accumulating information on papers by Russian scientists, published in native and foreign titles. The RSCI project is under development since 2005 by “Electronic Scientific Library” foundation (elibrary.ru).
- Google Scholar is a freely accessible web search engine that indexes the full text of scholarly literature across an array of publishing formats and disciplines. The Google Scholar index includes most peer-reviewed online journals of Europe and America's largest scholarly publishers, plus scholarly books and other non-peer reviewed journals.
- VINITI RAS
- Ulrich's
- iNeicon
- Open Archives
- RSL
- AcademicKeys
- Research Bible
- High Attestation Commission of Russian Federation
- ROAD
- RNMJ.RU
- DOAJ
Publishing Ethics
1. Introduction
1.1. The publication in a peer reviewed learned journal, serves many purposes outside of simple communication. It is a building block in the development of a coherent and respected network of knowledge. For all these reasons and more it is important to lay down standards of expected ethical behaviour by all parties involved in the act of publishing: the author, the journal editor, the peer reviewer, the publisher and the society for society-owned or sponsored journal: "Pelvic Surgery and Oncology"
1.2.Publisher has a supporting, investing and nurturing role in the scholarly communication process but is also ultimately responsible for ensuring that best practice is followed in its publications.
1.3. Publisher takes its duties of guardianship over the scholarly record extremely seriously. Our journal programmes record «the minutes of science» and we recognise our responsibilities as the keeper of those «minutes» in all our policies not least the ethical guidelines that we have here adopted.
2. Duties of Editors
2.1.Publication decision – The Editor of a learned "Pelvic Surgery and Oncology" is solely and independently responsible for deciding which of the articles submitted to the journal should be published, often working on conjunction with the relevant society (for society-owned or sponsored journals). The validation of the work in question and its importance to researchers and readers must always underwrite such decisions. The Editor may be guided by the policies of the "Pelvic Surgery and Oncology" journal’s editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editor may confer with other editors or reviewers (or society officers) in making this decision.
2.2.Fair play – An editor should evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.
2.3.Confidentiality – The editor and any editorial staff of "Pelvic Surgery and Oncology" must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.
2.4.Disclosure and Conflicts of interest
2.4.1. Unpublished materials disclosed in a submitted manuscript must not be used in an editor’s own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.
2.4.2. Editors should recuse themselves (i.e. should ask a co-editor, associate editor or other member of the editorial board instead to review and consider) from considering manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or (possibly) institutions connected to the papers.
2.5.Vigilance over published record – An editor presented with convincing evidence that the substance or conclusions of a published paper are erroneous should coordinate with the publisher (and/or society) to promote the prompt publication of a correction, retraction, expression of concern, or other note, as may be relevant.
2.6.Involvement and cooperation in investigations – An editor should take reasonably responsive measures when ethical complaints have been presented concerning a submitted manuscript or published paper, in conjunction with the publisher (or society). Such measures will generally include contacting the author of the manuscript or paper and giving due consideration of the respective complaint or claims made, but may also include further communications to the relevant institutions and research bodies.
3. Duties of Reviewers
3.1.Contribution to Editorial Decisions – Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper. Peer review is an essential component of formal scholarly communication, and lies at the heart of the scientific method. Publisher shares the view of many that all scholars who wish to contribute to publications have an obligation to do a fair share of reviewing.
3.2.Promptness – Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor of "Pelvic Surgery and Oncology" and excuse himself from the review process.
3.3.Confidentiality – Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorised by the editor.
3.4.Standard and objectivity – Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.
3.5.Acknowledgement of Sources – Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor’s attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.
3.6.Disclosure and Conflict of Interest
3.6.1.Unpublished materials disclosed in a submitted manuscript must not be used in a reviewer’s own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.
3.6.2. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.
4. Duties of Authors
4.1.Reporting standards
4.1.1. Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behaviour and are unacceptable.
4.1.2. Review and professional publication articles should also be accurate and objective, and editorial 'opinion’ works should be clearly identified as such.
4.2.Data Access and Retention – Authors may be asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.
4.3.Originality and Plagiarism
4.3.1. The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others, this has been appropriately cited or quoted.
4.3.2. Plagiarism takes many forms, from ‘passing off’ another’s paper as the author’s own paper, to copying or paraphrasing substantial parts of another’s paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behaviour and is unacceptable.
4.4.Multiple, Redundant or Concurrent Publication
4.4.1. An author should not in general publish manuscripts describing essentially the same research in more than one journal of primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behaviour and is unacceptable.
4.4.2. In general, an author should not submit for consideration in another journal a previously published paper.
4.4.3. Publication of some kinds of articles (eg, clinical guidelines, translations) in more than one journal is sometimes justifiable, provided certain conditions are met. The authors and editors of the journals concerned must agree to the secondary publication, which must reflect the same data and interpretation of the primary document. The primary reference must be cited in the secondary publication. Further detail on acceptable forms of secondary publication can be found at www.icmje.org.
4.5.Acknowledgement of Sources – Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work. Information obtained privately, as in conversation, correspondence, or discussion with third parties, must not be used or reported without explicit, written permission from the source. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services.
4.6.Authorship of the Paper
4.6.1. Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors.
4.6.2. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.
4.7.Hazards and Human or Animal Subjects
4.7.1. If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript.
4.7.2. If the work involves the use of animal or human subjects, the author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) have approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
4.8. Disclosure and Conflicts of Interest
4.8.1. All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.
4.8.2. Examples of potential conflicts of interest which should be disclosed include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Potential conflicts of interest should be disclosed at the earliest possible stage.
4.9. Fundamental errors in published works – When an author discovers a significant error or inaccuracy in a published work, it is the author’s obligation to promptly notify the editor of "Pelvic Surgery and Oncology" journal and cooperate with Publisher to retract or correct the paper, If the editor or the publisher learn from a third party that a published work contains a significant error, it is the obligation of the author to promptly retract or correct the paper.
5. Duties of the Publisher (and if relevant, Society)
5.1. Publisher should adopt policies and procedures that support editors, reviewers and authors of "Pelvic Surgery and Oncology" in performing their ethical duties under these ethics guidelines. The publisher should ensure that the potential for advertising or reprint revenue has no impact or influence on editorial decisions.
5.2. The publisher should support "Pelvic Surgery and Oncology" journal editors in the review of complaints raised concerning ethical issues and help communications with other journals and/or publishers where this is useful to editors.
5.3. Publisher should develop codes of practice and inculcate industry standards for best practice on ethical matters, errors and retractions.
5.4. Publisher should provide specialised legal review and counsel if necessary.
The section is prepared according to the files (http://health.elsevier.ru/attachments/editor/file/ethical_code_final.pdf) of Elsevier publisher (https://www.elsevier.com/) and files (http://publicationethics.org/resources) from Committee on Publication Ethics (COPE - http://publicationethics.org/).
Founder and Publisher
Publisher
“PH “ABV-press”, LLC
24 bldg. 15 Kashirskoye shosse, 115478, Moscow
Author Fees
Publication in "Pelvic Surgery and Oncology" is free of charge for all the authors.
The journal doesn't have any Arcticle processing charges.
The journal doesn't have any Article submission charges.
Disclosure and Conflict of Interest
Unpublished materials disclosed in a submitted manuscript must not be used in a reviewer’s own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.
Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.
Borrowing and Plagiarism
Publication of works containing plagiarism of text, ideas, data is prohibited. Authors should submit fully original works. Results of other authors’ work should be appropriately cited or quoted; quotations of a text previously published should be written as the direct speech with the obligatory indication of the original source.
The editorial board of the journal checks the material using plagiarism detection software Antiplagiat and Google Scholarto screen the submissions. In case of identification of illegally borrowed text and graphic elements, low coefficient of originality of the text, the editors have the right to demand to correct the article or refuse to publish it.
Detection of plagiarism is also carried out as part of an open peer review. If plagiarism is identified, the editorial board acts in accordance with the COPE guidelines. Even published article will be retracted if plagiarism will be found.
Article Retraction
According to the rules of the Council on Ethics of Scientific Publications of Association of Science Editors and Publishers, the grounds for article retraction are:
- detection of plagiarism in the article;
- detection of falsifications (for example, manipulation of experimental data);
- detection of serious errors that cast doubt on scientific value of the article;
- incorrect list of authors;
- duplication of the article in several journals;
- republishing the article without the author’s consent;
- concealment of conflict of interest and other violations of publication ethics;
- the fact that the article hasn’t been peer reviewed.
After the decision to retract the article is made, the chief editor informs its authors, indicating the reason and date of retraction. The article remains on the journal’s site as part of the corresponding journal issue, but is marked “Retracted” with the retraction date (the mark is placed on top of the text of the article and in the table of contents); in addition, a message about retraction is placed in the news section of the site, and the chief editor sends information about the article retraction to all online libraries and databases in which the journal is indexed.
Advertising and Reprints Circulation
The editorial policy of the journal “Surgery and Oncology” and the publisher in the field of advertising is based on the recommendations of the World Association of Medical Editors (WAME) Recommendations on Publication Ethics Policies for Medical Journals and the Law of the Russian Federation “On Advertising”.
- The journal publisher may generate income from advertising and reprints, which creates a potential conflict of interest. To avoid the impact of this circumstance on the publication process, editorial decisions are not influenced by the cost of advertising or the production of reprints. Advertisers and sponsors have no influence on editorial and editorial board decisions, regardless of the terms of advertising or other agreements.
- All advertising materials are subject to the approval of the editorial staff, which reserves the right to reject or cancel the display of any advertisement at any time.
- The roles and responsibilities of the magazine editors and the publisher's advertising managers do not overlap.
- In scholarly publications and on the journal's Web site, it is prohibited to intentionally place advertisements next to articles about the company or product that is the subject of the advertisement. Advertising content is designed differently from scholarly and editorial publications so that the difference between the two is obvious.
- Materials from sponsors and/or advertisers should be clearly labeled as advertisements.
- The editorial board of the journal has the right to reject any advertisement that, in the opinion of the editorial board, is incompatible with its mission or is not in line with the objectives of the journal/journal website or the publisher.
- Advertisements must not be misleading and must be verifiable, must clearly identify the advertiser and the product or service offered. Distortions, exaggerations or extravagant language in advertisements are not permitted.
- By submitting advertising materials for consideration, the advertiser and advertising agency, jointly and severally, agree to be responsible (including liability) for any claims against the publisher, its officers, agents and employees and to indemnify for costs and damages incurred as a result of the publication of the advertisement in question, its content, including (including agreeing to be defendants for allegations of libel, breach of confidentiality, copyright infringement or plagiarism).
- Any mention of the publisher and the magazine, their products or services in advertisements, promotional materials or merchandise by an advertiser or advertising agency requires the written permission of the publisher.
- Advertising of medicines and medical services must comply with the requirements of Russian law.
- While the publisher welcomes advertisements with a high proportion of textual content and data, advertisements should not resemble scholarly articles and peer-reviewed content; advertisers' banners and logos should be clearly distinguishable, and the advertising content itself may require special labeling. All promotional materials must clearly and uniquely identify the advertiser by trademark and/or signature.
- Reprints should only be published as originally published in the magazine (including subsequent corrections), so there should be no additions or changes.
- The publisher is not liable for incidental or consequential damages due to errors in the display or printing of advertisements.
- Advertisements published in the journal do not imply that the advertiser has sponsored the journal or had any influence on the authors of any article, the editorial review process and the editorial decision to allow publication in the journal/website.
